Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
St. Barnabas Medical Center
mi
from
Livingston, NJ
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
St. Barnabas Medical Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
St. Joseph's Hospital and Medical Center
mi
from
Paterson, NJ
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
St. Joseph's Hospital and Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Mount Sinai Medical Center, NY
mi
from
New York, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Rhode Island Hospital
mi
from
Providence, RI
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Click here to add this to my saved trials
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Androgen Receptor Mutations in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Graham Hospital
mi
from
Canton, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Memorial Hospital
mi
from
Carthage, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Eureka Hospital
mi
from
Eureka, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Eureka Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/7/2015
InterCommunity Cancer Center of Western Illinois
mi
from
Galesburg, IL
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/7/2015
InterCommunity Cancer Center of Western Illinois
mi
from
Galesburg, IL
Click here to add this to my saved trials